Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Short squeeze coming up ...
View:
Post by Mole101 on Nov 04, 2020 1:31pm

Short squeeze coming up ...

  • Oct 15, 2020
    Shares Shorted: 467,797 
    Net Change: 9,565
  • Sep 30, 2020
    Shares Shorted: 458,232 
    Net Change: -119,185
  • Sep 15, 2020
    Shares Shorted: 577,417 
    Net Change: 90,710
  • Aug 31, 2020
    Shares Shorted: 486,707 
    Net Change: -63,089
  • Aug 15, 2020
    Shares Shorted: 549,796 
    Net Change: 112,227
  • Jul 3
Comment by TopBroker on Nov 04, 2020 1:56pm
With a 12 cent financing not being closed I cannot see a short squeeze. This further shows that if you are a Doctor stay in medicine and let professionals handle finance. Biogen is up 100 dollars and your Comopany is up 2 cents and you believe there is a short squeeze, hardly my friend. Your Board is financially inept and they continue to show it.
Comment by Mole101 on Nov 04, 2020 2:01pm
Whatever you say shorty ..
Comment by M101 on Nov 04, 2020 2:03pm
lol, "short squeeze" has just become the most "interesting" comment I've ever read on this board.
Comment by TopBroker on Nov 04, 2020 2:13pm
You are right and I generally would agree with you but logic is logic and if you can sell and buy back cheaper, then where is the short squeeze?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities